Background: Mutations in SOD1, ANG, VAPB, TARDBP and FUS genes have been identified in amyotrophic lateral sclerosis (ALS).

Methods: The relative contributions of the different mutations to ALS were estimated by systematically screening a cohort of 162 families enrolled in France and 500 controls (1000 chromosomes) using molecular analysis techniques and performing phenotype-genotype correlations.

Results: 31 pathogenic missense mutations were found in 36 patients (20 SOD1, 1 ANG, 1 VAPB, 7 TARDBP and 7 FUS). Surprisingly two FUS mutation carriers also harboured ANG variants. One family of Japanese origin with the P56S VAPB mutation was identified. Seven novel mutations (three in SOD1, two in TARDBP, two in FUS) were found. None of them was detected in controls. Segregation of detected mutations with the disease was confirmed in 11 families including five pedigrees carrying the novel mutations. Clinical comparison of SOD1, TARDBP, FUS and other familial ALS patients (with no mutation in the screened genes) revealed differences in site of onset (predominantly lower limbs for SOD1 and upper limbs for TARDBP mutations), age of onset (younger with FUS mutations), and in lifespan (shorter for FUS carriers). One third of SOD1 patients survived more than 7 years: these patients had earlier disease onset than those presenting with a more typical course. Differences were also observed among FUS mutations, with the R521H FUS mutation being associated with longer disease duration.

Conclusions: This study identifies new genetic associations with ALS and provides phenotype-genotype correlations with both previously reported and novel mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmg.2010.077180DOI Listing

Publication Analysis

Top Keywords

tardbp fus
20
sod1 ang
12
ang vapb
12
vapb tardbp
12
fus mutations
12
novel mutations
12
mutations
11
fus
10
amyotrophic lateral
8
lateral sclerosis
8

Similar Publications

Amyotrophic lateral sclerosis (ALS) is a devastating, uniformly lethal degenerative disease of motor neurons, presenting with relentlessly progressive muscle atrophy and weakness. More than fifty genes carrying causative or disease-modifying variants have been identified since the 1990s, when the first ALS-associated variant in the gene SOD1 was discovered. The most commonly mutated ALS genes in the European populations include the C9orf72, SOD1, TARDBP and FUS.

View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. Four major genes associated with ALS-SOD1, TARDBP, FUS, and C9orf72-have been identified, with the fused in sarcoma (FUS) gene demonstrating considerable genetic heterogeneity. Our research group has previously established an induced pluripotent stem (iPS) cell line harboring the c.

View Article and Find Full Text PDF
Article Synopsis
  • ALS is a progressive neurodegenerative disease affecting motor neurons, leading to severe motor dysfunction and respiratory failure, with varying global incidence primarily in individuals aged 45-80.
  • The disease is driven by genetic factors (like mutations in specific genes) and environmental influences, highlighting its complex pathogenesis involving protein misfolding, mitochondrial issues, oxidative stress, and neuroinflammation.
  • Current treatments focus on symptom management, with ongoing research into gene therapy and stem cell therapy, but effective solutions are still in early development, necessitating further exploration of ALS's genetics for targeted therapies.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the mitofusin 2 gene, which is essential for mitochondrial functions and is linked primarily to Charcot-Marie-Tooth disease type 2A, but also seen in some amyotrophic lateral sclerosis (ALS) cases.
  • Researchers analyzed 385 ALS patients in Italy from 2008 to 2023, identifying 12 rare mutations in 19 individuals, with 8 variants showing potential pathogenic relevance.
  • The clinical features observed included various ALS types, and patients showed a wide range of survival durations, indicating a need for further exploration of the impact of these mutations on motor neuron diseases.
View Article and Find Full Text PDF

The Effect of Dipeptide Repeat Proteins on FUS/TDP43-RNA Condensation in C9orf72 ALS/FTD.

J Phys Chem B

October 2024

Zernike Institute for Advanced Materials, University of Groningen, Groningen 9747AG, the Netherlands.

Condensation of RNA binding proteins (RBPs) with RNA is essential for cellular function. The most common familial cause of the diseases ALS and FTD is C9orf72 repeat expansion disorders that produce dipeptide repeat proteins (DPRs). We explore the hypothesis that DPRs disrupt the native condensation behavior of RBPs and RNA through molecular interactions resulting in toxicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!